Upcoming activities:
23rd SCAC: Fourth Industrial Revolution and Future Society (26-28, Oct'24)
Recent activities
On-Spot Project Review (BAS-USDA 6th Phase)- Jun'24
Fellow CV
List of Publications
(Fellow, 2025)
Dr. Fahima Chowdhury
Senior Scientist, Infectious Disease Division, icddr,b, Dhaka
EDUCATION
Degree Year Institution
MBBS 1994 Mymensingh Medical College
MPH 2009 North South University
Ph.D. 2023 Griffith University, Australia
Professional Activities
AWARDS
2005 - International Nutrition Foundation (USA)/Ellison Foundation Fellowship Award
2008 - Fogarty International Clinical Research Scholar, NIH, Bethesda, Maryland, USA
2010-11 International Alumni at ‘Fogarty International Clinical Research Scholars '
2018- Humanitarian Recognition Award for leading ‘OCV campaign in the Rohingya
Population’
2019- Awarded to attend US-Japan International Conference on Emerging Infectious
Diseases in Vietnam
2022- Awarded to present ‘Winning Abstracts’ in ASCODD
2023- Awarded for Wellcome infectious disease funding call on oral cholera vaccine
2025- Awarded by Harvard Global Institute and Gates to discuss Future Cholera in UK
2026- Travel award through Gates Foundation to attend Diarrheal Disease Surveillance, in Goa, India
2026- Travel award for the “Shigella: from biology to prevention”, at the Institute of Pasteur in Paris, France
PUBLICATIONS: ~160
As first, senior or corresponding author ~40 publication
Chowdhury F, Ahmmed F, et al. Epidemiological and Clinical Features of Enterotoxigenic Escherichia coli Diarrhea in an Urban Slum. Open Forum Infectious Diseases. 2025.
Akhtar M, Chowdhury F, Qadri F. Spike specific IgG3 and nucleocapsid IgG response in serum serve as distinguishing immunological markers between SARS-CoV-2 infection and vaccination. Front Immunol. 2025;(Senior Author)
Ahmed T, Chowdhury F, Ruvoën-Clouet N. COVID-19 and blood group-related antigens: provide innate protection from symptomatic SARS-CoV-2 infection? Front Med. 2025 (Senior Author)
Rahman SIA, Chowdhury F. Genomic insights into a diarrheal outbreak in Bangladesh reveal novel ETEC lineages and expansion of CS23 colonization factor. 2025 Spectrum Microbiology (Senior Author).
Akter A, Chowdhury F. A comparative assessment of data completeness of the adverse events following immunization in DHIS2. J Health Popul Nutr. 2025. (Senior Author).
Akter A, Chowdhury F. Risk Factors for Death in Patients with Dengue Fever in Dhaka, Bangladesh: A Verbal Autopsy Study. Cureus. 2025. (Senior Author)
RESEARCH GRANT
1.NIH/NICHD funded. 2019-2024. The effect of single-dose azithromycin in contacts of cholera patients; Role: PI
25. Global Task Force. Assessment of the DHIS2 Adverse Events Following Immunization tracker in Bangladesh. Role: PI
26. Wellcome Trust, Title: Case-area targeted interventions (CATIs) among household contacts defining cholera hotspot areas in Bangladesh: Role: PI
27. USAID. ‘Clinical and laboratory factors for the progression of severe Dengue among hospitalized patients. Role: Co-PI